Use the Search Fields to Find Information
Page 7 of 357
Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws
Abstract Background Highly-potent cannabis products, e.g., concentrates, entail greater risks of cannabis-related harms than lower-potency products such as plant or flower material. However, little information
May 22, 2025
Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia
Please use this link to access this publication. Abstract Cohort studies and meta-analyses have documented a robust association between cannabis use, heavy use, and misuse
June 7, 2025
Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child
Objective: To evaluate the effectiveness of dronabinol (delta-9-THC) as supplementary therapy in a child with autistic disorder. Methods: A child who met the DSM-IV (Diagnostic
September 19, 2019
Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
The use of cannabidiol (CBD)-rich hemp-based nutraceuticals is increasing in dogs and cats for disorders related to anxiety, seizures, cancer and pain. To date, there
April 7, 2020
Use of Cannabis-Based Medical Products for Pediatric Health Conditions: A Systematic Review of the Recent Literature
Abstract Introduction: Cannabis policy is rapidly changing in the USA and across the globe, with 24 states legalizing cannabis for adult use and 38 states making
February 27, 2025
Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary
Abstract Medical cannabis patients consistently report using cannabis as a substitute for prescription medications; however, little is known about individuals accessing cannabis through adult-use markets.
November 22, 2023
Use of Cannabis in Fetal Alcohol Spectrum Disorder
Please use this link to access this publication. Abstract Background: Fetal alcohol spectrum disorder (FASD) has been recently estimated to afflict up to 5% of American
November 4, 2024
Use of Cannabis for Self-Management of Chronic Pelvic Pain
Please use this link to access this publication. Abstract Background: Chronic pelvic pain (CPP) affects up to 15% of women in the United States. The endocannabinoid
June 7, 2025
Use of cannabis for mental health in the Canadian territories: a cross-sectional study
Please use this link to access this publication. Abstract Background Population prevalence and patterns of cannabis use for mental health (CUMH) are underexplored. This is
December 4, 2024
Page 7 of 357